# DIVALPROEX SODIUM
> **ANDA217358** · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA · Approved 2025-08-12
## Drug
- **FDA Application Number:** ANDA217358
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DIVALPROEX SODIUM
- **Generic name:** DIVALPROEX SODIUM
- **Active ingredients:** DIVALPROEX SODIUM
- **Dosage form:** CAPSULE, DELAYED REL PELLETS
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MANKIND PHARMA
- **Manufacturer:** First Nation Group, LLC
- **First approval:** 2025-08-12
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217358)
---
*AI Analytics · CC0 1.0*